Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization.

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8f5049c45b097ada-LAX IP: 116.62.10.13 UTC time: 2024-12-20T14:23:04+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4